Issue Date | Title | Author(s) | Type | Мp-cat. |
---|---|---|---|---|
2025 | Altered levels of sphingolipid metabolites in serum of locally advanced rectal cancer patients: a pilot study | Bjelanović, Jasna; Nikolić, Aleksandra ![]() ![]() ![]() ![]() ![]() ![]() | Article | 23M23 |
2025 | Comprehensive pharmacogenomics profiling of the Serbian population | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2025 | NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease | Zudeh, Giulia; Selvestrel, Davide; Bramuzzo, Matteo; Cecchin, Erika; D’Andrea, Monica; Stanković, Biljana ![]() ![]() ![]() ![]() ![]() ![]()
Stocco, Gabriele; Lucafò, Marianna;
| Article | 21aM21a |
2025 | High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia![]() | Tošić, Nataša M. ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | CAN NUDT15 BE PHARMACOGENETIC OR PHARMACOTRANSRIPTOMIC MARKER FOR 6- MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN SERBIA | Ristivojević, Bojan; Kotur, Nikola ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | EXPLORING VARIATION IN ADHESION G PROTEIN-COUPLED RECEPTOR GENES: INSIGHTS FROM GENOMIC DATASETS OF PEDIATRIC RARE DISEASE CASES IN SERBIA | Pavlović, Đorđe ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | Pharmacogenomic landscape of Serbian population | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity | Curci, Debora; Stanković, Biljana ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | POPULATION PHARMACOGENOMICS OF IMMUNOSUPPRESSIVE AND AMINOSALICYLATE THERAPY: POTENTIAL FOR THERAPY OPTIMIZATION IN SERBIAN PAEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | Using Singular Value Decomposition for Extracting Underlying Gene Expression Patterns in Transcriptomic Analysis | Stanković, Biljana ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | Genome-wide association study identified genetic signal in cystatin genes associated with Long COVID-19 | Laban-Lazović, Marija; Zečević, Marko; Kotur, Nikola ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2024 | Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation | Dragašević, Sanja; Stanković, Biljana ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2024 | NEW GATA3 VARIANT IN A PATIENT WITH BARAKAT SYNDROME | Marjanović, Irena ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Covid-19 disease severity associated with vitamin d related genetic Variants | Kotur, Nikola ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Can pharmacogenetic variants in TPMT, MTHFR and SLCO1B1 genes be used as potential markers of outcome prediction in systemic sclerosis patients? | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | In Silico analysis and prediction of novel pharmacogenomic markers of pediatric ALL treatment | Gašić, Vladimir ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia | Ristivojević, Bojan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |
2023 | Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients? | Jelovac, Marina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Article | 21M21 |
2023 | Micronutrients, genetics and COVID-19 | Kotur, Nikola ![]() ![]() ![]() ![]() ![]() ![]() | Article | 22M22 |
2023 | NUDT15 AS POTENTIAL MARKER FOR PHARMACOGENETIC-GUIDED 6-MERCAPTOPURINE THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN SERBIA![]() | Ristivojević, Bojan ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | Conference Paper | Mp. category will be shown later |